MINJUVI
MINJUVI
Approved
DIN Number
02518627
Drug Class
Human
Market Date
Dec 6, 2021
Company
HC
因塞特
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02518627
AIG Number0163075001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FX12 TAFASITAMAB
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
TAFASITAMABActive
Strength: 200 MG / VIAL
Monograph: TAFASITAMAB